Giant Cell Carcinoma of Lung with Aberrant Cytoplasmic Localization of P63 Protein

Authors

  • Cyrus Parsa

Keywords:

giant cell carcinoma, aberrant p63, lung carcinoma

Abstract

Giant Cell Carcinoma is a rare, aggressive type of lung malignancy and very few cases have been extensively studied and reported to date. Because of its rare occurrence, this neoplasm is often not included in the classifications of usual lung cancers. It is considered by some as a variant of undifferentiated large cell carcinoma. Giant cells have, however, been found to occur in different types of lung cancers and their presence in any histologic type is associated with a significantly worse outcome. We present a non-smoking female who was diagnosed with lung adenocarcinoma composed of many giant cells showing cytoplasmic expression of p63 protein. Admitting imaging studies revealed metastases to liver, lymph nodes and the pelvic region. Due to the rarity of this cancer, the diagnosis as well as therapeutic and prognostic features of giant cell carcinoma is often overlooked.

How to Cite

Giant Cell Carcinoma of Lung with Aberrant Cytoplasmic Localization of P63 Protein. (2014). Global Journal of Medical Research, 14(55), 1-6. https://medicalresearchjournal.org/index.php/GJMR/article/view/

References

L. Horn, W. Pao, D. Johnson Chapter 89. Neoplasms of the Lung.

Attanoos, Papagiannis, Suttinont, Goddard, Papotti, Gibbs (1998) Pulmonary giant cell carcinoma: pathological entity or morphological phenotype?. 32(3), 225-231. https://doi.org/10.1046/j.1365-2559.1998.00378.x

Nancy Fishback, William Travis, Cesar Moran, D. Guinee, William McCarthy, Michael Koss (1994) Pleomorphic (spindle/giant cell) carcinoma of the lung. A clinicopathologic correlation of 78 cases. 73(12), 2936-2945. https://doi.org/10.1002/1097-0142(19940615)73:12

Teresa Alasio, Wei Sun, Grace Yang (2007) Giant cell carcinoma of the lung impact of diagnosis and review of cytological features. Diagn. 35(9), 555-559. https://doi.org/10.1002/dc.20701

Bruce Addis, Ann Dewar, Nicola Thurlow (1988) Giant cell carcinoma of the lung-immunohistochemical and ultrastructural evidence of dedifferentiation. 155(3), 231-240. https://doi.org/10.1002/path.1711550309

Seemayer Wang N-S, Knaack Ahmed MN (1976) Giant cell carcinoma of the lung: A light and electron microscopic study. 7, 3-16.

Jung Hong, Moon Choi, Ji Uhm, Min Park, Jeeyun Lee, Yeon Park, Jin Ahn, Keunchil Park, Joung Han, Myung Ahn (2009) The role of palliative chemotherapy for advanced pulmonary pleomorphic carcinoma. 26(3), 287-291. https://doi.org/10.1007/s12032-008-9117-4

Yuki T, Sakuma T, Ohbayashi C, Yoshimura M (2007) Pleomorphic carcinoma of the lung: A surgical outcome. 134(2), 399-404. https://doi.org/10.1016/j.jtcvs.2007.04.018

J. Rosai, Rosai, Ackerman (2011) Rosai and Ackerman's Surgical Pathology. 373.

T. Narahashi, T. Niki, T. Wang, A. Goto, D. Matsubara, N. Funata, M. Fukayama (2006) Cytoplasmic localization of p63 is associated with poor patient survival in lung adenocarcinoma. 49(4), 349-357.

Giant Cell Carcinoma of Lung with Aberrant Cytoplasmic Localization of P63 Protein

Published

2014-11-21

How to Cite

Giant Cell Carcinoma of Lung with Aberrant Cytoplasmic Localization of P63 Protein. (2014). Global Journal of Medical Research, 14(55), 1-6. https://medicalresearchjournal.org/index.php/GJMR/article/view/